| Greenhy2 Limited (H2G) ORDINARY FULLY PAID |
Industrials |
$11 |
Quarterly Activities Report and Appendix 4C - December 2024
|
31 Jan 2025 8:42AM |
$0.003 |
$0.018 |
risen by
500%
|
|
H2G - Price-sensitive ASX Announcement
Full Release
Key Points
- Cash on hand at the end of the quarter was $1,041K, decreasing from $1,105K last quarter.
- Focus on core Renewable Energy Strategy, particularly Solid State Hydrogen Storage Batteries.
- The market for Solar Storage solutions is extensive, targeting utilities, telecoms, and remote communities.
- Partnership with Telstra to trial dual Hydrogen storage systems for telecommunications.
- Essential Energy completed a performance trial with 100% availability and renewable fraction.
- Negotiations ongoing for additional technology arrangements to reduce costs significantly.
- Cash flow report details receipts from customers and payments to related parties.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Control Bionics Limited (CBL) ORDINARY FULLY PAID |
Health Care |
$10 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jan 2025 8:42AM |
$0.061 |
$0.035 |
fallen by
42.62%
|
|
CBL - Price-sensitive ASX Announcement
Full Release
Key Points
- Record U.S. revenue of nearly $1 million.
- First HCPCS reimbursements received.
- Expansion into U.S. sports performance and Japanese rehabilitation markets.
- Implemented A$700,000 in annualised cost savings.
- Successful capital raise of $2.47 million.
- Focus on NeuroStrip® technology and growth in new markets.
- Strategic investment in Neuro Elite Athletics.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Fluence Corporation Limited (FLC) ORDINARY FULLY PAID |
Utilities |
$41 |
Appendix 4C - Quarterly
|
31 Jan 2025 8:42AM |
$0.067 |
$0.038 |
fallen by
43.28%
|
|
FLC - Price-sensitive ASX Announcement
Full Release
Key Points
- Net cash from operating activities was negative at $3,027,000.
- The company received $4,805,000 from financing activities.
- Cash and cash equivalents at the end of the quarter were $8,945,000.
- Total loan facilities amounted to $20,815,000, with $20,101,000 drawn.
- The report is in compliance with ASX Listing Rule 4.7B.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Dragon Mountain Gold Limited (DMG) ORDINARY FULLY PAID |
Materials |
$2 |
Quarterly Cashflow and Activity Report
|
31 Jan 2025 8:42AM |
$0.005 |
$0.004 |
fallen by
20%
|
|
DMG - Price-sensitive ASX Announcement
Full Release
Key Points
- DMG's quarterly activity report for the period ending 31 December 2024.
- Exploration focused on Avalon and Cawse Projects.
- Avalon drilling program showed elevated gold concentrations.
- Preparations for Cawse Project drilling are in progress.
- Capital raise of $670,000 completed.
- Cash position at the end of the quarter was $366,000.
- Exploration expenditure compared to previous forecasts outlined.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Gas2Grid Limited (GGX) ORDINARY FULLY PAID |
Energy |
$4 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jan 2025 8:41AM |
$0.001 |
$0.001 |
fallen by
0%
|
|
| Beonic Ltd (BEO) ORDINARY FULLY PAID |
Information Technology |
$16 |
Beonic Quarterly Business Review and Appendix 4C
|
31 Jan 2025 8:41AM |
$0.250 |
$0.220 |
fallen by
12%
|
|
BEO - Price-sensitive ASX Announcement
Full Release
Key Points
- Recurring revenue reached $4.4 million, a 5.3% increase from the previous year.
- Annualized recurring revenue (ARR) stands at $17.6 million, reflecting a 4.3% growth.
- Gross margin improved to 77.4% compared to 68.5% in FY24.
- Net cash outflow from operations was $725,000, aided by capitalized R&D costs.
- Cost reductions led to a decrease in cash costs related to staff and administration.
- Key contract wins include JFK International Airport and LaTrobe City.
- Marc Thompson appointed as Chief Technology Officer effective February 10, 2025.
- Michael Pearce appointed as Company Secretary.
- Beonic launched the Investor Hub to enhance shareholder engagement.
- The company expects to achieve cash flow breakeven in H2 FY25.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Percheron Therapeutics Limited (PER) ORDINARY FULLY PAID |
Health Care |
$11 |
Quarterly Activities Report and Appendix 4C
|
31 Jan 2025 8:41AM |
$0.008 |
$0.011 |
risen by
31.25%
|
|
PER - Price-sensitive ASX Announcement
Full Release
Key Points
- Phase IIb study of avicursen in Duchenne muscular dystrophy terminated due to lack of efficacy.
- Company undergoing strategic review to find optimal path forward.
- Completed $13 million institutional placement and $1.85 million Share Purchase Plan.
- Proceeds from funding redirected towards new opportunities.
- Uplisted foreign shares to OTCQB, ticker changed to PERCF.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Advance Metals Limited (AVM) ORDINARY FULLY PAID |
Materials |
$14 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jan 2025 8:39AM |
$0.039 |
$0.052 |
risen by
33.33%
|
|
AVM - Price-sensitive ASX Announcement
Full Release
Key Points
- Acquisition of Yoquivo Silver Project in Mexico announced.
- Yoquivo Project has defined a Foreign Estimate of 937kt at 570g/t AgEq.
- Initial drilling program planned for confirmatory and extensional drilling at Yoquivo.
- Joint venture agreement entered for Myrtleford and Beaufort Gold Projects.
- Drilling at Myrtleford has returned high grade intercepts.
- New Managing Director Adam McKinnon appointed.
- Exploration work continues in Arizona on the Augustus Project.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| G8 Education Limited (GEM) ORDINARY FULLY PAID |
Consumer Discretionary |
$967 |
Update - Notification of buy-back - GEM
|
31 Jan 2025 8:39AM |
$1.375 |
$1.195 |
fallen by
13.09%
|
|
| Telix Pharmaceuticals Limited (TLX) ORDINARY FULLY PAID |
Health Care |
$8,788 |
Notification regarding unquoted securities - TLX
|
31 Jan 2025 8:38AM |
$28.810 |
$25.980 |
fallen by
9.82%
|
|
| Verity Resources Limited (VRL) ORDINARY FULLY PAID |
Materials |
$8 |
Release of Restricted Securities
|
31 Jan 2025 8:38AM |
$0.018 |
$0.028 |
risen by
55.56%
|
|
| Telix Pharmaceuticals Limited (TLX) ORDINARY FULLY PAID |
Health Care |
$8,788 |
Cleansing Notice
|
31 Jan 2025 8:37AM |
$28.810 |
$25.980 |
fallen by
9.82%
|
|
| Mirrabooka Investments Limited (MIR) ORDINARY FULLY PAID |
Financials |
$627 |
Update - Dividend/Distribution - MIR
|
31 Jan 2025 8:37AM |
$3.360 |
$3.220 |
fallen by
4.17%
|
|
| Insurance Australia Group Limited (IAG) ORDINARY FULLY PAID |
Financials |
$21,122 |
Business Interruption update
|
31 Jan 2025 8:36AM |
$8.930 |
$8.930 |
fallen by
0%
|
|
| Elixir Energy Limited (EXR) ORDINARY FULLY PAID |
Energy |
$41 |
Quarterly Activities Report and Appendix 5B Dec 2024
|
31 Jan 2025 8:35AM |
$0.045 |
$0.029 |
fallen by
35.56%
|
|
EXR - Price-sensitive ASX Announcement
Full Release
Key Points
- Operations at the Daydream-2 appraisal well were concluded.
- The Lorelle Sandstone flowed at stabilized rates of between 2.1 and 2.5 MMSCFD.
- A MOU was executed with AGIG for new gas infrastructure in the Taroom Trough.
- An increase in prospective resources of 712 Bcf was booked for ATP 2077.
- Elixir pursued farmout negotiations for the Grandis Project and Diona sub-block.
- Elixir has 100% interest in the Nomgon IX Coal Bed Methane PSC in Mongolia.
- Cash reserves as at December 31, 2024, were $2.7 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Telix Pharmaceuticals Limited (TLX) ORDINARY FULLY PAID |
Health Care |
$8,788 |
Application for quotation of securities - TLX
|
31 Jan 2025 8:35AM |
$28.810 |
$25.980 |
fallen by
9.82%
|
|
| Live Verdure Ltd (LV1) ORDINARY FULLY PAID |
Consumer Staple |
$144 |
LV1 December 2024 Quarterly Business Review & Appendix 4C
|
31 Jan 2025 8:35AM |
$0.900 |
$0.915 |
risen by
1.67%
|
|
LV1 - Price-sensitive ASX Announcement
Full Release
Key Points
- LV1 acquired a controlling interest in Decidr.ai through a $13.2 million interest-free loan.
- Decidr.ai secured multi-year subscriptions with customers in healthcare, FMCG, finance, energy, and media.
- Strategic partnerships were established with The Growth Faculty, CareerOne, and ELMO Software.
- Edible Beauty's e-commerce sales grew 64% year-on-year and 143% quarter-on-quarter.
- David Brudenell transitioned to Executive Chairman to focus on group growth.
- The company reported a closing cash position of $4.62 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Little Green Pharma Ltd (LGP) ORDINARY FULLY PAID |
Health Care |
$35 |
Quarterly Activities Report and Appendix 4C
|
31 Jan 2025 8:33AM |
$0.110 |
$0.115 |
risen by
4.55%
|
|
LGP - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue of $9.5 million, up 75% on prior corresponding period.
- Cash receipts of $10 million, up 90% on prior corresponding period.
- FY25Q3 year-to-date revenue of $27 million, surpassing prior full year revenue of $25.6 million.
- Strong German and UK market growth with $1 million in German flower sales in December.
- Launched new Lush Labs craft flower brand and multiple new oil products.
- Clinical trial treatment phase completed with positive feedback.
- Health House due diligence acquisition completed, negotiating SPA.
- Cash in bank of $3.7 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mayfield Childcare Limited (MFD) ORDINARY FULLY PAID |
Consumer Discretionary |
$26 |
Letter from the Chair
|
31 Jan 2025 8:33AM |
$0.430 |
$0.350 |
fallen by
18.60%
|
|
| Dubber Corporation Limited (DUB) ORDINARY FULLY PAID |
Information Technology |
$42 |
Proposed issue of securities - DUB
|
31 Jan 2025 8:33AM |
$0.054 |
$0.016 |
fallen by
70.37%
|
|
| Clime Capital Limited (CAM) ORDINARY FULLY PAID |
Financials |
$105 |
Application for quotation of securities - CAM
|
31 Jan 2025 8:33AM |
$0.775 |
$0.705 |
fallen by
9.03%
|
|
| Adherium Limited (ADR) ORDINARY FULLY PAID |
Health Care |
$5 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jan 2025 8:33AM |
$0.015 |
$0.007 |
fallen by
53.33%
|
|
ADR - Price-sensitive ASX Announcement
Full Release
Key Points
- Nearly 3,000 patients using Hailie® with pathway to reach 9,000 patients by calendar end 2025
- Customer receipts increased to $148,000, reflecting growing adoption and market traction
- AMC Health purchased 560 devices in December and placed a third order of 170 devices in January
- Potential entry into a new revenue segment: Pharmacy Benefit Management (PBM)
- Secured $674,000 R&D loan to support continued innovation
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Australian Dairy Nutritionals Group (AHF) ORDINARY FULLY PAID |
Consumer Staple |
$32 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jan 2025 8:32AM |
$0.065 |
$0.043 |
fallen by
33.85%
|
|
AHF - Price-sensitive ASX Announcement
Full Release
Key Points
- AHF reported net cash outflows from operations of $641,000 for Q2 FY25.
- Cash holdings at the end of Q2 FY25 were $4.48 million.
- The first production run for Nutura Organic has been completed successfully.
- The Future brand is set to be launched in China, with positive market feedback.
- Directors received $79,000 in remuneration during the December quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tabcorp Holdings Limited (TAH) ORDINARY FULLY PAID |
Consumer Discretionary |
$1,692 |
Formal appointment of Gillon McLachlan as MD & CEO
|
31 Jan 2025 8:31AM |
$0.665 |
$0.740 |
risen by
11.28%
|
|
| Lycaon Resources Limited (LYN) ORDINARY FULLY PAID |
Materials |
$8 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jan 2025 8:31AM |
$0.145 |
$0.130 |
fallen by
10.34%
|
|
LYN - Price-sensitive ASX Announcement
Full Release
Key Points
- Maiden drill program completed at Stansmore Niobium-Rare Earth Elements target.
- Best assay result of 1m @ 425ppm Nb+Nd+Pr and 217ppm Y+Yb received.
- EIS exploration incentive grant of up to $180,000 for drilling costs.
- Ongoing assessment of additional geophysical targets in the West Arunta Project.
- Changes in board and management, with Tony Rovira joining the Board.
- Directors committed to invest $450,000 into the Company.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
